본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Clinical epigenetics v.9 no.1, 2017년, pp.118 -    SCIE SCOPUS
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women

Schmitz, Martina    (oncgnostics GmbH, Jena, Germany   ); Wunsch, Kristina    (oncgnostics GmbH, Jena, Germany   ); Hoyer, Heike    (Institute of Medical Statistics, Information Sciences and Documentation, Jena University Hospital, Jena, Germany   ); Scheungraber, Cornelia    (Department of Gynaecology and Reproductive Medicine, Jena University Hospital, Jena, Germany   ); Runnebaum, Ingo B.    (Department of Gynaecology and Reproductive Medicine, Jena University Hospital, Jena, Germany   ); Hansel, Alfred    (oncgnostics GmbH, Jena, Germany   ); Dürst, Matthias    (Department of Gynaecology and Reproductive Medicine, Jena University Hospital, Jena, Germany  );
  • 초록  

    Background HPV DNA testing as a primary screening marker is being implemented in several countries. Due to the high HPV prevalence in the screening population, effective triage strategies for HPV-positive cases are required. The aim of this study was to evaluate the performance of a methylation-specific real-time PCR assay (GynTect?) comprising six marker regions as a triage test. Results An analytical sensitivity of 0.1 ng genomic DNA corresponding to 15 SiHa cells was achieved. Absolute specificity was observed in the presence of 20 ng unmethylated genomic DNA. In a clinical setting, cervical scrapes of 306 women showing abnormal colposcopy were tested for cytology, HPV positivity, and the GynTect markers ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671. Of all women, histopathological data were available. The overall sensitivity for GynTect to detect CIN3+ was 67.7% (95% CI 57.3%–77.1%) whereas sensitivity was significantly higher for women of age ≥ 30 years ( p = 0.04). All cancer cases ( n = 5) were detected by GynTect. The overall false positive rate (= 1-specificity) for women with no CIN was 17.4% (95% CI 12.5–23.1%), with a higher proportion among HPV-positive women (24.0%, 95% CI 16.0–33.6%). In a triage screening setting, where all women underwent HPV testing and the HPV positives in addition GynTect testing, the overall sensitivity would slightly decline but specificity would reach the maximum value of 88.7% (95% CI 83.7–92.6%). Conclusion The GynTect? assay is a robust easy to use assay with high analytical sensitivity and specificity. Moreover, the performance of the assay based on cervical scrapes provides further evidence for the usefulness of methylation markers to detect HPV-positive women with clinically relevant disease. Electronic supplementary material The online version of this article (10.1186/s13148-017-0419-2) contains supplementary material, which is available to authorized users.


  • 주제어

    Screening .   CIN .   Cervical cancer .   HPV .   Triage .   Methylation marker panel.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

유료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기